Comparison of cell attachment and caseinolytic activities of five tumour cell types

1978 ◽  
Vol 34 (1) ◽  
pp. 133-144
Author(s):  
J. Varani ◽  
W. Orr ◽  
P.A. Ward

We have examined the ability of 5 tumour cell types to attach to plastic flasks in medium containing either 10% foetal calf serum or 10% normal human serum and compared this ability with cell-associated caseinolytic activity. The cell types used included fibrosarcoma cells which were obtained from a methylcholanthrene-induced tumour in a C57 BL/6 mouse, the SV40-transformed 3T3 (BALB/c) cells, the Walker carcinosarcoma cells and 2 lines of HeLa cells. All 5 cell types attached to the flasks and spread out efficiently in medium containing 10% foetal calf serum. The walker carcinosarcoma cells and the 2 lines of HeLa cells also attached efficiently in medium containing 10% normal human serum and grew into monolayers in this medium. These 3 cell types had no detectable caseinolytic activity. The fibrosarcoma cells and the SV40-transformed 3T3 (BALB/c) cells did not attach in normal human serum-containing medium. These 2 cell types had readily detected caseinolytic activity. Normal human serum and foetal calf serum were compared for levels of protease-inhibitor activity. Human serum was found to have less activity than foetal calf serum against both trypsin and plasmin as well as the cell-associated caseinolytic activity. The low level of protease inhibitor activity in normal human serum may contribute to the inability of this serum to support the attachment of cells with detectable protease activity because the addition of protease inhibitors such as soybean trypsin inhibitor, lima bean trypsin inhibitor and bovine pancreas trypsin inhibitor to normal human serum dramatically enhanced cell attachment. In contrast to this, the addition of E-amino-n-caproic acid to normal human serum and the removal of plasminogen from normal human serum did not enhance its capacity to support cell attachment.

1979 ◽  
Vol 36 (1) ◽  
pp. 241-252
Author(s):  
J. Varani ◽  
W. Orr ◽  
P.A. Ward

The in vitro migratory activity of mouse fibrosarcoma cells in medium containing either foetal calf serum or normal human serum was studied. These 2 sera were studied because foetal calf serum contains high levels of protease inhibitor activity while human serum contains much less. The cells migrated actively in medium with foetal calf serum but migration was greatly inhibited in human serum-containing medium. When protease inhibitors such as soybean trypsin inhibitor, lima bean trypsin inhibitor and bovine pancreas trypsin inhibitor were added to human serum-containing medium cell migration was supported almost as effectively as in medium with foetal calf serum. Addition of epsilon-amino-n-caproic acid to human serum or depletion of the plasminogen from human serum did not enable it to support enhanced migration. epsilon-amino-n-caproic acid actually inhibited migration. A variant cell population with elevated levels of caseinolytic activity and elevated levels of activity against the substrate n-acetyl-DL-phenylalanine-beta-naphthyl ester (a substrate specific for chymotrypsin-like enzymes) was isolated from the parent cells. When the variant cells were compared to the parent cells regarding migratory activity in foetal calf serum or human serum-containing medium, the variant cells showed much less activity. Only a few, widely scattered variant cells migrated in the human serum-containing medium. These data suggest that a cell-associated factor interferes with the migration of the cells in medium with human serum. This factor apparently is neutralized in medium sontaining human serum to which protease inhibitors with antitrypsin activity have been added.


1959 ◽  
Vol 1 (1) ◽  
pp. 66-71
Author(s):  
Egil Gjone ◽  
James F. Berry ◽  
David A. Turner

1982 ◽  
Vol 28 (1) ◽  
pp. 119-121 ◽  
Author(s):  
E Piall ◽  
G W Aherne ◽  
V Marks

Abstract We evaluated a commercially available (Diagnostic Biochemistry Inc.) doxorubicin 125I radioimmunoassay kit. This kit gave a high apparent doxorubicin concentration (greater than 12 micrograms/L), which was not linearly related to dilution, for two pools of normal human serum and plasma and also for samples collected from patients before they received the drug. In contrast, a doxorubicin 3H radioimmunoassay developed by us gave a low blank (2 micrograms/L), which was linearly related to dilution, for the same pools and patients' samples. Doxorubicin concentrations in the plasma of patients receiving the drug were compared by the two methods; the kit gave results five- to 10-fold those obtained with our assay. High nonspecific interference by serum and plasma as measured by the 125I radioimmunoassay must therefore be borne in mind by users of the kit, and we suggest that results should be corrected for these nonspecific effects.


Biochemistry ◽  
1963 ◽  
Vol 2 (2) ◽  
pp. 286-289 ◽  
Author(s):  
Walter N. Shaw ◽  
Eldon W. Shuey

1979 ◽  
Vol 21 (2) ◽  
pp. 190-195 ◽  
Author(s):  
C.D.R. Dunn ◽  
N. Do

2003 ◽  
Vol 10 (2) ◽  
pp. 216-220
Author(s):  
Marlene Pereira de Carvalho Florido ◽  
Patrícia Ferreira de Paula ◽  
Lourdes Isaac

ABSTRACT Due to the increasing numbers of reported clinical cases of complement deficiency in medical centers, clinicians are now more aware of the role of the complement system in the protection against infections caused by microorganisms. Therefore, clinical laboratories are now prepared to perform a number of diagnostic tests of the complement system other than the standard 50% hemolytic component assay. Deficiencies of alternative complement pathway proteins are related to severe and recurrent infections; and the application of easy, reliable, and low-cost methods for their detection and distinction are always welcome, notably in developing countries. When activation of the alternative complement pathway is evaluated in hemolytic agarose plates, some but not all human sera cross-react to form a late linear lysis. Since the formation of this linear lysis is dependent on C3 and factor B, it is possible to use late linear lysis to routinely screen for the presence of deficiencies of alternative human complement pathway proteins such as factor B. Furthermore, since linear lysis is observed between normal human serum and primary C3-deficient serum but not between normal human serum and secondary C3-deficient serum caused by the lack of factor H or factor I, this assay may also be used to discriminate between primary and secondary C3 deficiencies.


Sign in / Sign up

Export Citation Format

Share Document